Guidance

Conversion of Community Marketing Authorisations (CAPs) to Great Britain Marketing Authorisations (MAs) - letter to industry

A letter providing guidance on the post-transition conversion process was sent by email on 23 October 2020 to the Community MA holders.

From:
Medicines and Healthcare products Regulatory Agency
Published
26 October 2020

Documents

Conversion of Community Marketing Authorisations (CAPs) to Great Britain Marketing Authorisations (MAs)

HTML

Conversion of Community Marketing Authorisations (CAPs) to Great Britain Marketing Authorisations (MAs)

PDF, 43 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Following the end of the transition period we will put in place arrangements for the continued authorisation of medicinal products. This letter was sent to inform you of the actions we intend to take concerning CAPs and the actions we need you to take as a Marketing Authorisation Holder (MAH) of a CAP.

If your company holds one or more Community MAs and has not received our letter, please email capconversion@mhra.gov.uk so that we can verify the appropriate contact details.

For further information, please email our Customer Services Centre at RIS.NA@mhra.gov.uk. You can also email capconversion@mhra.gov.uk with urgent questions. Alternatively, contact your Trade Association by emailing:

Published 26 October 2020

Related content